Methotrexate and sulfasalazine combination therapy: Is it worth the risk?
- 1 February 1993
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 36 (2) , 281-282
- https://doi.org/10.1002/art.1780360226
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugsBiochemical Journal, 1992
- The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritisArthritis & Rheumatism, 1990
- Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long‐term treatmentArthritis & Rheumatism, 1989
- Drug interactions with methotrexateBritish Journal of Dermatology, 1989
- Folate status of rheumatoid arthritis patients receiving long‐term, low‐dose methotrexate therapyArthritis & Rheumatism, 1987
- SULPHASALAZINE: A ‘NEW’ ANTIRHEUMATIC DRUGRheumatology, 1984